Literature DB >> 15080016

Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections.

Z Zakay-Rones1, E Thom, T Wollan, J Wadstein.   

Abstract

Elderberry has been used in folk medicine for centuries to treat influenza, colds and sinusitis, and has been reported to have antiviral activity against influenza and herpes simplex. We investigated the efficacy and safety of oral elderberry syrup for treating influenza A and B infections. Sixty patients (aged 18-54 years) suffering from influenza-like symptoms for 48 h or less were enrolled in this randomized, double-blind, placebo-controlled study during the influenza season of 1999-2000 in Norway. Patients received 15 ml of elderberry or placebo syrup four times a day for 5 days, and recorded their symptoms using a visual analogue scale. Symptoms were relieved on average 4 days earlier and use of rescue medication was significantly less in those receiving elderberry extract compared with placebo. Elderberry extract seems to offer an efficient, safe and cost-effective treatment for influenza. These findings need to be confirmed in a larger study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15080016     DOI: 10.1177/147323000403200205

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  40 in total

Review 1.  Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies.

Authors:  Haider Abdul-Lateef Mousa
Journal:  J Evid Based Complementary Altern Med       Date:  2016-04-06

2.  Confirmation Bias as a Factor in Pharmacy Student Assessment of Research Study Quality.

Authors:  Donald R Miller; Stefanie J Jangula
Journal:  Am J Pharm Educ       Date:  2019-06       Impact factor: 2.047

3.  A Pragmatic Approach to Immunity & Respiratory Viral Infections.

Authors:  Todd A Born
Journal:  Integr Med (Encinitas)       Date:  2020-10

4.  Nutritional and Physical Activity Interventions to Improve Immunity.

Authors:  Glen Davison; Corinna Kehaya; Arwel Wyn Jones
Journal:  Am J Lifestyle Med       Date:  2014-11-25

5.  Discriminant Analyses of the Polyphenol Content of American Elderberry Juice from Multiple Environments Provide Genotype Fingerprint.

Authors:  Mitch C Johnson; Matheus Dela Libera Tres; Andrew L Thomas; George E Rottinghaus; C Michael Greenlief
Journal:  J Agric Food Chem       Date:  2017-05-11       Impact factor: 5.279

Review 6.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Authors:  Dâmaris Silveira; Jose Maria Prieto-Garcia; Fabio Boylan; Omar Estrada; Yris Maria Fonseca-Bazzo; Claudia Masrouah Jamal; Pérola Oliveira Magalhães; Edson Oliveira Pereira; Michal Tomczyk; Michael Heinrich
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

Review 7.  Natural Supplements for COVID19-Background, Rationale, and Clinical Trials.

Authors:  Melody Hermel; Megan Sweeney; Yu-Ming Ni; Robert Bonakdar; Douglas Triffon; Christopher Suhar; Sandeep Mehta; Sarah Dalhoumi; James Gray
Journal:  J Evid Based Integr Med       Date:  2021 Jan-Dec

8.  Antimicrobial activity and synergism of some substituted flavonoids.

Authors:  M A Alvarez; N B Debattista; N B Pappano
Journal:  Folia Microbiol (Praha)       Date:  2008-05-15       Impact factor: 2.099

9.  Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Michael Macknin; Kathy Wolski; Jeffrey Negrey; Sharon Mace
Journal:  J Gen Intern Med       Date:  2020-09-14       Impact factor: 5.128

10.  Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses.

Authors:  Christian Krawitz; Mobarak Abu Mraheil; Michael Stein; Can Imirzalioglu; Eugen Domann; Stephan Pleschka; Torsten Hain
Journal:  BMC Complement Altern Med       Date:  2011-02-25       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.